| Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy MN Bouchlaka, GD Sckisel, M Chen, A Mirsoian, AE Zamora, E Maverakis, ... Journal of Experimental Medicine 210 (11), 2223-2237, 2013 | 154 | 2013 |
| Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice A Mirsoian, MN Bouchlaka, GD Sckisel, M Chen, CCS Pai, E Maverakis, ... Journal of Experimental Medicine 211 (12), 2373-2383, 2014 | 136 | 2014 |
| Out-of-sequence signal 3 paralyzes primary CD4+ T-cell-dependent immunity GD Sckisel, MN Bouchlaka, AM Monjazeb, M Crittenden, BD Curti, ... Immunity 43 (2), 240-250, 2015 | 127 | 2015 |
| Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy JK Tietze, DEC Wilkins, GD Sckisel, MN Bouchlaka, KL Alderson, ... Blood, The Journal of the American Society of Hematology 119 (13), 3073-3083, 2012 | 99 | 2012 |
| Development of AO-176, a next-generation humanized anti-CD47 antibody with novel anticancer properties and negligible red blood cell binding RJ Puro, MN Bouchlaka, RR Hiebsch, BJ Capoccia, MJ Donio, ... Molecular Cancer Therapeutics 19 (3), 835-846, 2020 | 72 | 2020 |
| Human mesenchymal stem cell–educated macrophages are a distinct high IL-6–producing subset that confer protection in graft-versus-host-disease and radiation injury models MN Bouchlaka, AB Moffitt, J Kim, JA Kink, DD Bloom, C Love, S Dave, ... Biology of Blood and Marrow Transplantation 23 (6), 897-905, 2017 | 68 | 2017 |
| FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma Y Li, MN Bouchlaka, J Wolff, KM Grindle, L Lu, S Qian, X Zhong, N Pflum, ... Oncogene 35 (48), 6223-6234, 2016 | 65 | 2016 |
| 19F-MRI for monitoring human NK cells in vivo MN Bouchlaka, KD Ludwig, JW Gordon, MP Kutz, BP Bednarz, SB Fain, ... Oncoimmunology 5 (5), e1143996, 2016 | 65 | 2016 |
| Increased antitumor effects using IL-2 with anti–TGF-β reveals competition between mouse NK and CD8 T cells M Alvarez, MN Bouchlaka, GD Sckisel, CM Sungur, M Chen, WJ Murphy The Journal of Immunology 193 (4), 1709-1716, 2014 | 53 | 2014 |
| Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects MN Bouchlaka, D Redelman, WJ Murphy Immunotherapy 2 (3), 399-418, 2010 | 51 | 2010 |
| Mechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responses MN Bouchlaka, GD Sckisel, D Wilkins, E Maverakis, AM Monjazeb, ... PloS one 7 (10), e48049, 2012 | 40 | 2012 |
| An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells NAP Lieberman, K DeGolier, K Haberthur, H Chinn, KW Moyes, ... Frontiers in Immunology 9, 150, 2018 | 27 | 2018 |
| Impact of aging in cancer immunotherapy: The importance of using accurate preclinical models MN Bouchlaka, WJ Murphy Oncoimmunology 2 (12), e27186, 2013 | 22 | 2013 |
| IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation K Sun, HH Hsiao, M Li, E Ames, M Bouchlaka, LA Welniak, T Hagino, ... The Journal of Immunology 189 (4), 2033-2042, 2012 | 22 | 2012 |
| Analysis of ex vivo expanded and activated clinical-grade human NK cells after cryopreservation SN Damodharan, KL Walker, MH Forsberg, KA McDowell, MN Bouchlaka, ... Cytotherapy 22 (8), 450-457, 2020 | 15 | 2020 |
| Late administration of murine CTLA-4 blockade prolongs CD8-mediated anti-tumor effects following stimulatory cancer immunotherapy GD Sckisel, A Mirsoian, MN Bouchlaka, JK Tietze, M Chen, BR Blazar, ... Cancer immunology, immunotherapy 64, 1541-1552, 2015 | 13 | 2015 |
| CXCR4 allows T cell acute lymphoblastic leukemia to escape from JAK1/2 and BCL2 inhibition through CNS infiltration KL Walker, SP Rinella, NJ Hess, DP Turicek, SA Kabakov, F Zhu, ... Leukemia & lymphoma 62 (5), 1167-1177, 2021 | 12 | 2021 |
| Therapeutic purposes and risks of ex vivo expanded mesenchymal stem/stromal cells MN Bouchlaka, P Hematti, CM Capitini Mesenchymal Stromal Cells as Tumor Stromal Modulators; Bolontrade, MF …, 2016 | 9 | 2016 |
| Synergistic co-targeting of BTK and BCL2 in mantle cell lymphoma Y Li, MN Bouchlaka, K Grindle, BS Kahl, S Miyamoto, DT Yang, ... Blood 126 (23), 708, 2015 | 7 | 2015 |
| Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2+ Murine Neuroblastoma PD Bates, AL Rakhmilevich, MM Cho, MN Bouchlaka, SL Rao, JM Hales, ... Frontiers in immunology 12, 668307, 2021 | 5 | 2021 |
